Australia's most trusted
source of pharma news
Wednesday, 15 January 2025
Posted 11 September 2024 PM
Life insurance companies will be banned from discriminating against people based on genetic testing results under Federal Government moves designed to save lives and safeguard the future of precision medicine and genomic research.
Advocates for change have campaigned for the ban for a decade with AstraZeneca, the Australian Academy of Health and Medical Sciences (AAHMS), and Monash University researchers among the loudest of supporters.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.